HeartSciences (HSCS) Operating Expenses (2021 - 2026)

HeartSciences (HSCS) has reported Operating Expenses for 6 consecutive years, with $2.5 million the latest figure, recorded in Q2 2026.

• Quarterly Operating Expenses rose 31.91% year-over-year to $2.5 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $6.5 million (down 22.36% YoY) and the FY2026 annual result came in at $8.4 million, up 0.72% from the prior year.
• Operating Expenses climbed to $2.5 million in Q2 2026 per HSCS's latest filing, from $2.1 million in the prior quarter.
• Over the last five years, Operating Expenses for HSCS reached as high as $2.5 million in Q2 2026 and fell as low as $1.1 million in Q1 2022.
• A 5-year average of $1.8 million and a median of $1.9 million in 2025 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses soared 111.67% — and 2023, when it slipped 19.29%.
• Year by year, Operating Expenses stood at $1.8 million in 2022, then fell by 11.41% to $1.6 million in 2023, then climbed by 26.25% to $2.0 million in 2024, then grew by 4.52% to $2.1 million in 2025, then rose by 22.25% to $2.5 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $2.5 million, $2.1 million, and $1.9 million for Q2 2026, Q4 2025, and Q3 2025 respectively.